Relay Therapeutics, Inc. (RLAY) Tops Q4 EPS by 12c

Relay Therapeutics, Inc. (NASDAQ: RLAY) reported Q4 EPS of ($0.45), $0.12 better than the analyst estimate of ($0.57).

For earnings history and earnings-related data on Relay Therapeutics, Inc. (RLAY) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• Cerebras Q1 EPS miss sends shares down 9% after-hours
• Kepler Cheuvreux Upgrades Koninklijke KPN NV (KPN:NA) (KKPNY) to Buy